Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C
Clinical trial NCT00120835 · COMPLETED
Trial details
- NCT number
- NCT00120835
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.